Clinical Trial Results:
A Multicenter, Double-blind, Randomised, Parallel Group, Placebo-controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SR™) as Mono-therapy in the Treatment of Elderly Patients with Generalised Anxiety Disorder (CHROMIUM Study).
Summary
|
|
EudraCT number |
2006-001195-21 |
Trial protocol |
EE |
Global completion date |
01 Apr 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
05 Oct 2016
|
First version publication date |
05 Oct 2016
|
Other versions |
|
Summary report(s) |
CSR-D1448C00015_Redacted |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.